what-when-how
In Depth Tutorials and Information
[98] Xiao J, Madhan B, Li Y, Brodsky B, Baum J. Osteogenesis
imperfecta model peptides: incorporation of residues replac-
ing Gly within a triple helix achieved by renucleation and local
lexibility. Biophys J 2011;101(2):449-58.
[99] Cheng H, Rashid S, Yu Z, Yoshizumi A, Hwang E, Brodsky B.
Location of glycine mutations within a bacterial collagen pro-
tein affects degree of disruption of triple-helix folding and con-
formation. J Biol Chem 2011;286(3):2041-6.
secretory pathway of tendon ibroblasts in situ. Biochem J
2012;441(2):707-17.
[117]
Bateman JF, Golub SB. Assessment of procollagen processing
defects by ibroblasts cultured in the presence of dextran sul-
phate. Biochem J 1990;267(3):573-7.
[118]
Wallis GA, Starman BJ, Schwartz MF, Byers PH. Substitution of
arginine for glycine at position 847 in the triple-helical domain
of the alpha 1 (I) chain of type I collagen produces lethal osteo-
genesis imperfecta. Molecules that contain one or two abnor-
mal chains differ in stability and secretion. J Biol Chem 1990;
265(30):18628-18633.
[100]
Hyde TJ, Bryan MA, Brodsky B, Baum J. Sequence dependence
of renucleation after a Gly mutation in model collagen pep-
tides. J Biol Chem 2006;281(48):36937-43.
[101]
Raghunath M, Bruckner P, Steinmann B. Delayed triple helix
formation of mutant collagen from patients with osteogenesis
imperfecta. J Mol Biol 1994;236(3):940-9.
[119]
Bateman JF, Mascara T, Chan D, Cole WG. Abnormal type I
collagen metabolism by cultured ibroblasts in lethal perinatal
osteogenesis imperfecta. Biochem J 1984;217(1):103-15.
[102]
Persikov AV, Pillitteri RJ, Amin P, Schwarze U, Byers PH,
Brodsky B. Stability related bias in residues replacing glycines
within the collagen triple helix (Gly-Xaa-Yaa) in inherited con-
nective tissue disorders. Hum Mutat 2004;24(4):330-7.
[120]
Kadler KE, Hojima Y, Prockop DJ. Assembly of collagen ibrils
de novo by cleavage of the type I pC-collagen with procollagen
C-proteinase. Assay of critical concentration demonstrates that
collagen self-assembly is a classical example of an entropy-driven
process. J Biol Chem 1987;262(32):15696-701.
[103]
Makareeva E, Cabral WA, Marini JC, Leikin S. Molecular mech-
anism of alpha 1(I)-osteogenesis imperfecta / Ehlers-Danlos
syndrome - unfolding of an N-anchor domain at the N-terminal
end of the type I collagen triple helix. J Biol Chem 2006;
281(10):6463-70.
[121]
Kadler KE, Hill A, Canty-Laird EG. Collagen ibrillogenesis:
ibronectin, integrins, and minor collagens as organizers and
nucleators. Curr Opin Cell Biol 2008;20(5):495-501.
[122]
Gioia R, Panaroni C, Besio R, Palladini G, Merlini G,
Giansanti V, et al. Impaired osteoblastogenesis in a murine model
of dominant osteogenesis imperfecta: a new target for osteo-
genesis imperfecta pharmacological therapy. Stem Cells 2012;
30(7):1465-76.
[104]
Nagai N, Hosokawa M, Itohara S, Adachi E, Matsushita T,
Hosokawa N, et  al. Embryonic lethality of molecular chaper-
one Hsp47 knockout mice is associated with defects in collagen
biosynthesis. J Cell Biol 2000;150(6):1499-506.
[105]
Ono T, Miyazaki T, Ishida Y, Uehata M, Nagata K. Direct in
vitro and in vivo evidence for interaction between Hsp47 pro-
tein and collagen triple helix. J Biol Chem 2012;287(9):6810-8.
[123]
Uveges TE, Collin-Osdoby P, Cabral WA, Ledgard F, Goldberg L,
Bergwitz C, et  al. Cellular mechanism of decreased bone in Brtl
mouse model of OI: imbalance of decreased osteoblast function
and increased osteoclasts and their precursors. J Bone Miner Res
2008;23(12):1983-94.
[106]
Gotkin MG, Ripley CR, Lamande SR, Bateman JF, Bienkowski RS.
Intracellular traficking and degradation of unassociated proal-
pha2 chains of collagen type I. Exp Cell Res 2004;296(2):307-16.
[124]
Kuznetsova NV, Forlino A, Cabral WA, Marini JC, Leikin S.
Structure, stability and interactions of type I collagen with
GLY349-CYS substitution in alpha 1(I) chain in a murine
Osteogenesis Imperfecta model. Matrix Biol 2004;23(2):101-12.
[107]
Stefanovic B, Brenner DA. 5′ stem-loop of collagen alpha 1(I)
mRNA inhibits translation in vitro but is required for triple heli-
cal collagen synthesis in vivo. J Biol Chem 2003;278(2):927-33.
[108]
Patterson GH, Hirschberg K, Polishchuk RS, Gerlich D, Phair
RD, Lippincott-Schwartz J. Transport through the Golgi appa-
ratus by rapid partitioning within a two-phase membrane sys-
tem. Cell 2008;133(6):1055-67.
[125]
Panaroni C, Gioia R, Lupi A, Besio R, Goldstein SA, Kreider J,
et  al. In utero transplantation of adult bone marrow decreases
perinatal lethality and rescues the bone phenotype in the knockin
murine model for classical, dominant osteogenesis imperfecta.
Blood 2009;114(2):459-68.
[109]
Chessler SD, Byers PH. Defective folding and stable asso-
ciation with protein disulide isomerase / prolyl hydroxylase
of type I procollagen with a deletion in the pro alpha 2(I) chain
that preserves the Gly-X-Y repeat pattern. J Biol Chem 1992;
267(11):7751-7.
[126]
Fleischmajer R, Olsen BR, Timpl R, Perlish JS, Lovelace O.
Collagen ibril formation during embryogenesis. Proc Natl
Acad Sci USA 1983;80(11):3354-8.
[127]
Eyre DR, Shapiro FD, Aldridge JF. A heterozygous collagen
defect in a variant of the Ehlers-Danlos syndrome type VII.
Evidence for a deleted amino-telopeptide domain in the pro-
alpha 2(I) chain. J Biol Chem 1985;260(20):11322-29.
[110]
Fromme JC, Schekman R. COPII-coated vesicles: lexible
enough for large cargo? Curr Opin Cell Biol 2005;17(4):345-52.
[111]
Wilson DG, Phamluong K, Li L, Sun M, Cao TC, Liu PS, et al.
Global defects in collagen secretion in a Mia3 / TANGO1 knock-
out mouse. J Cell Biol 2011;193(5):935-51.
[128]
Romanic AM, Adachi E, Hojima Y, Engel J, Prockop DJ.
Polymerization of pNcollagen I and copolymerization of pNcol-
lagen I with collagen I. A kinetic, thermodynamic, and morpho-
logic study. J Biol Chem 1992;267(31):22265-71.
[112]
Saito K, Chen M, Bard F, Chen S, Zhou H, Woodley D, et  al.
TANGO1 facilitates cargo loading at endoplasmic reticulum
exit sites. Cell 2009;136(5):891-902.
[129]
Hulmes DJ, Kadler KE, Mould AP, Hojima Y, Holmes DF,
Cummings C, et  al. Pleomorphism in type I collagen ibrils pro-
duced by persistence of the procollagen N-propeptide. J Mol Biol
1989;210(2):337-45.
[113]
Saito K, Yamashiro K, Ichikawa Y, Erlmann P, Kontani K,
Malhotra V, et al. cTAGE5 mediates collagen secretion through
interaction with TANGO1 at endoplasmic reticulum exit sites.
Mol Biol Cell 2011;22(13):2301-8.
[130]
Cole WG, Chan D, Chambers GW, Walker ID, Bateman JF.
Deletion of 24 amino acids from the pro-alpha 1(I) chain of
type I procollagen in a patient with the Ehlers-Danlos syn-
drome type VII. J Biol Chem 1986;261(12):5496-503.
[114]
Jin L, Pahuja KB, Wickliffe KE, Gorur A, Baumgartel C,
Schekman R, et  al. Ubiquitin-dependent regulation of COPII
coat size and function. Nature 2012;482(7386):495-500.
[115]
Canty EG, Lu Y, Meadows RS, Shaw MK, Holmes DF,
Kadler KE. Coalignment of plasma membrane channels and pro-
trusions (ibripositors) speciies the parallelism of tendon. J Cell
Biol 2004;165(4):553-63.
[131]
Nusgens BV, Verellendumoulin C, Hermannsle T, Depaepe A,
Nuytinck L, Pierard GE, et al. Evidence for a relationship between
Ehlers-Danlos type-VII-C in humans and bovine dermatospo-
raxis. Nat Genet 1992;1(3):214-7.
[116]
Canty-Laird EG, Lu Y, Kadler KE. Stepwise proteolytic
activation of type I procollagen to collagen within the
[132]
Steinmann B, Tuderman L, Peltonen L, Martin GR, McKusick VA,
Prockop DJ. Evidence for a structural mutation of procollagen
Search WWH ::




Custom Search